ConductScience.org, home

Paper7650486

Activation and expression of the nuclear factors of activated T cells, NFATp and NFATc, in human natural killer cells: regulation upon CD16 ligand binding.

Aramburu J and 3 others. J Exp Med, 1995. Cited by 125 papers, by iCite.

Cite this record

ConductScience Library. Activation and expression of the nuclear factors of activated T cells, NFATp and NFATc, in human natural killer cells: regulation upon CD16 ligand binding. Papers, record 7650486. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7650486

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Activation and expression of the nuclear factors of activated T cells, NFATp and NFATc, in human natural killer cells: regulation upon CD16 ligand binding.
PubMed
Journal
J Exp Med
PubMed
Year
1995
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
125
iCite
Relative citation ratio, by iCite
2.13
iCite
Revised in PubMed
2019-12-10
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Aramburu JJ
2Azzoni LL
3Rao AA
4Perussia BB

Source PubMed

Download CSV of authors

Topics25

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
DNA-Binding ProteinsMajor topic
Gene Expression RegulationMajor topic
Killer Cells, NaturalMajor topic
Nuclear ProteinsMajor topic
Receptors, IgGMajor topic
Transcription FactorsMajor topic
Animals
Antibodies, Monoclonal
Antigen-Antibody Complex
B-Lymphocytes
Base Sequence
Cell Line, Transformed
Chlorocebus aethiops
Cyclosporine
Cytokines
Humans
Interleukin-12
Interleukin-2
Leukemia-Lymphoma, Adult T-Cell
Ligands
Lymphocyte Activation
Mice
Molecular Sequence Data
NFATC Transcription Factors
Tumor Cells, Cultured

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
CA37155NCI NIH HHSUnited StatesR01CA037155PubMed and NIHNIH RePORTER
CA45284NCI NIH HHSUnited StatesR01CA045284PubMed and NIHNIH RePORTER

Download CSV of grants

References48

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
16828386Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei.Nucleic Acids Res1983https://conductscience.org/library/papers/6828386PubMed
27739550NFATx, a novel member of the nuclear factor of activated T cells family that is expressed predominantly in the thymus.Mol Cell Biol1995https://conductscience.org/library/papers/7739550PubMed
32831292Interaction of Fc receptor (CD16) ligands induces transcription of interleukin 2 receptor (CD25) and lymphokine genes and expression of their products in human natural killer cells.J Exp Med1988https://conductscience.org/library/papers/2831292PubMed
42846696Signal transduction during human natural killer cell activation: inositol phosphate generation and regulation by cyclic AMP.J Immunol1988https://conductscience.org/library/papers/2846696PubMed
52536067
Fc gamma R(CD16) interaction with ligand induces Ca2+ mobilization and phosphoinositide turnover in human natural killer cells. Role of Ca2+ in Fc gamma R(CD16)-induced transcription and expression of lymphokine genes.
J Exp Med1989https://conductscience.org/library/papers/2536067PubMed
62493506Tumor targets stimulate IL-2 activated killer cells to produce interferon-gamma and tumor necrosis factor.J Immunol1989https://conductscience.org/library/papers/2493506PubMed
72683611Biology of natural killer cells.Adv Immunol1989https://conductscience.org/library/papers/2683611PubMed
81702384The actions of cyclosporin A and FK506 suggest a novel step in the activation of T lymphocytes.EMBO J1990https://conductscience.org/library/papers/1702384PubMed
91707162The immunosuppressives FK 506 and cyclosporin A inhibit the generation of protein factors binding to the two purine boxes of the interleukin 2 enhancer.Nucleic Acids Res1991https://conductscience.org/library/papers/1707162PubMed
102054113Lymphokine-activated killer cells, natural killer cells and cytokines.Curr Opin Immunol1991https://conductscience.org/library/papers/2054113PubMed
111712901The immunosuppressant FK-506 specifically inhibits mitogen-induced activation of the interleukin-2 promoter and the isolated enhancer elements NFIL-2A and NF-AT1.Mol Cell Biol1991https://conductscience.org/library/papers/1712901PubMed
121715516Nuclear association of a T-cell transcription factor blocked by FK-506 and cyclosporin A.Nature1991https://conductscience.org/library/papers/1715516PubMed
131910686Fc receptors.Annu Rev Immunol1991https://conductscience.org/library/papers/1910686PubMed
141730723A T cell nuclear factor resembling NF-AT binds to an NF-kappa B site and to the conserved lymphokine promoter sequence "cytokine-1".J Biol Chem1992https://conductscience.org/library/papers/1730723PubMed
151740667The AP-1 site at -150 bp, but not the NF-kappa B site, is likely to represent the major target of protein kinase C in the interleukin 2 promoter.J Exp Med1992https://conductscience.org/library/papers/1740667PubMed
161314888Signal transduction by Fc gamma RIII (CD16) is mediated through the gamma chain.J Exp Med1992https://conductscience.org/library/papers/1314888PubMed
171533441Nuclear factor of activated T cells contains Fos and Jun.Nature1992https://conductscience.org/library/papers/1533441PubMed
181281217Stimulation of Fc gamma RIIIA results in phospholipase C-gamma 1 tyrosine phosphorylation and p56lck activation.J Exp Med1992https://conductscience.org/library/papers/1281217PubMed
191281550Transcription of the tumor necrosis factor alpha gene is rapidly induced by anti-immunoglobulin and blocked by cyclosporin A and FK506 in human B cells.Proc Natl Acad Sci U S A1992https://conductscience.org/library/papers/1281550PubMed
208428966Characterization of the nuclear and cytoplasmic components of the lymphoid-specific nuclear factor of activated T cells (NF-AT) complex.J Biol Chem1993https://conductscience.org/library/papers/8428966PubMed

See all 48 referencesDownload CSV of references

Cited by62

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 125 citations.

PMIDTitleJournalYearIn PapersSource
42687675Association of Ferritin Levels With Cytokine Release Syndrome in CAR T-Cell Therapy: A Systematic Review and Meta-Analysis.Cancer Med2026https://conductscience.org/library/papers/42687675PubMed
42389534FcγRIIA signalling as a host-associated determinant of endosomal trafficking and antibody-dependent enhancement in flavivirus infection.Front Immunol2026https://conductscience.org/library/papers/42389534PubMed
40088333Unlocking the therapeutic potential of the NFAT pathway in kidney diseases.Naunyn Schmiedebergs Arch Pharmacol2025https://conductscience.org/library/papers/40088333PubMed
39563446Arachidonic acid impairs natural killer cell functions by disrupting signaling pathways driven by activating receptors and reactive oxygen species.Cell Commun Signal2024https://conductscience.org/library/papers/39563446PubMed
39479216NK Cells: Not Just Followers But Also Initiators of Chronic Vascular Rejection.Transpl Int2024https://conductscience.org/library/papers/39479216PubMed
39379603Silencing of SIRPα enhances the antitumor efficacy of CAR-M in solid tumors.Cell Mol Immunol2024https://conductscience.org/library/papers/39379603PubMed
39053944Enhanced IL-15-mediated NK cell activation and proliferation by an ADAM17 function-blocking antibody involves CD16A, CD137, and accessory cells.J Immunother Cancer2024https://conductscience.org/library/papers/39053944PubMed
38785735Role of B Cells beyond Antibodies in HBV-Induced Oncogenesis: Fulminant Cancer in Common Variable Immunodeficiency-Clinical and Immunotransplant Implications with a Review of the Literature.Diseases2024https://conductscience.org/library/papers/38785735PubMed
38635551Enhanced cytotoxic activity of natural killer cells from increased calcium influx induced by electrical stimulation.PLoS One2024https://conductscience.org/library/papers/38635551PubMed
37675125Protein O-GlcNAcylation in multiple immune cells and its therapeutic potential.Front Immunol2023https://conductscience.org/library/papers/37675125PubMed
36401631FK506 impairs neutrophil migration that results in increased polymicrobial sepsis susceptibility.Inflamm Res2023https://conductscience.org/library/papers/36401631PubMed
35774414Modularisation of published and novel models toward a complex KIR2DL4 pathway in pbNK cell.MethodsX2022https://conductscience.org/library/papers/35774414PubMed
35720368From CD16a Biology to Antibody-Dependent Cell-Mediated Cytotoxicity Improvement.Front Immunol2022https://conductscience.org/library/papers/35720368PubMed
35671888Cell-based reporter assays for measurements of antibody-mediated cellular cytotoxicity and phagocytosis against SARS-CoV-2 spike protein.J Virol Methods2022https://conductscience.org/library/papers/35671888PubMed
35550603The optimized core peptide derived from CABIN1 efficiently inhibits calcineurin-mediated T-cell activation.Exp Mol Med2022https://conductscience.org/library/papers/35550603PubMed
35479087Inhibition of O-GlcNAcylation Decreases the Cytotoxic Function of Natural Killer Cells.Front Immunol2022https://conductscience.org/library/papers/35479087PubMed
34908173Epigenetic regulation of natural killer cell memory.Immunol Rev2022https://conductscience.org/library/papers/34908173PubMed
34804035Generation of an NFκB-Driven Alpharetroviral "All-in-One" Vector Construct as a Potent Tool for CAR NK Cell Therapy.Front Immunol2021https://conductscience.org/library/papers/34804035PubMed
33467027Engineering Anti-Tumor Monoclonal Antibodies and Fc Receptors to Enhance ADCC by Human NK Cells.Cancers (Basel)2021https://conductscience.org/library/papers/33467027PubMed
33440654
ADCC against MICA/B Is Mediated against Differentiated Oral and Pancreatic and Not Stem-Like/Poorly Differentiated Tumors by the NK Cells; Loss in Cancer Patients due to Down-Modulation of CD16 Receptor.
Cancers (Basel)2021https://conductscience.org/library/papers/33440654PubMed

See all 62 cited byDownload CSV of cited by

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
FCGR3A2214PubTator's text mininghttps://conductscience.org/library/genes/2214NCBI Gene
JUNB3726PubTator's text mininghttps://conductscience.org/library/genes/3726NCBI Gene
NFATC14772PubTator's text mininghttps://conductscience.org/library/genes/4772NCBI Gene
NFATC24773PubTator's text mininghttps://conductscience.org/library/genes/4773NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/7650486

GET https://conductscience.org/api/papers/v1/7650486/references?page=2